샘플 요청 목록

 카트 문의
시장보고서
상품코드
1779751

세계의 센트럴 랩 시장

Central Labs
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 290 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 센트럴 랩 시장은 2030년까지 46억 달러에 달할 전망

2024년에 34억 달러로 추정되는 세계의 센트럴 랩 시장은 2024-2030년에 CAGR 5.3%로 성장하며, 2030년에는 46억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 유전자 서비스는 CAGR 6.2%를 기록하며, 분석 기간 종료시에는 14억 달러에 달할 것으로 예측됩니다. 바이오마커 서비스 분야의 성장률은 분석 기간 중 CAGR 5.5%로 추정됩니다.

미국 시장은 9억 2,400만 달러로 추정, 중국은 CAGR 8.5%로 성장 예측

미국의 센트럴 랩 시장은 2024년에는 9억 2,400만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 9억 3,100만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 8.5%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.5%와 5.3%로 예측됩니다. 유럽에서는 독일이 CAGR 3.5%로 성장할 것으로 예측됩니다.

세계의 센트럴 랩 시장 - 주요 동향과 촉진요인 정리

중앙연구소에 대한 수요가 증가하는 이유는 무엇인가?

중앙연구소는 임상시험에서 중요한 역할을 담당하고 있으며, 의약품 개발 및 규제 당국의 승인에 필수적인 표준화된 고품질 검사 서비스를 제공합니다. 특히 종양학, 신경학, 감염학 분야의 임상시험이 증가하면서 중앙검사실 서비스에 대한 수요가 증가하고 있습니다. 제약 및 바이오테크놀러지 기업은 진단 검사 및 바이오마커 분석의 일관성, 규정 준수 및 효율성을 보장하기 위해 실험실 기능을 중앙 실험실에 아웃소싱하고 있습니다. 또한 임상시험의 복잡성이 증가하면서 약동학, 유전체학, 동반진단 등 전문적인 검사 서비스가 요구되고 있습니다. 다기관 시험에 대응할 수 있는 신뢰성과 확장성이 높은 검사 서비스에 대한 요구는 스폰서 및 의약품 개발 수탁기관(CRO)을 중앙연구소와의 제휴로 유도하고 있습니다. 세계 임상연구의 전망이 확대됨에 따라 정밀의료 구상을 지원하는 중앙연구소의 역할이 점점 더 중요해지고 있습니다.

기술 발전은 중앙 연구소를 어떻게 변화시키고 있는가?

실험실 자동화, 인공지능(AI), 디지털 병리학(Digital Pathology)의 혁신은 중앙 실험실 운영에 혁명을 일으키고 있습니다. 첨단 액체 크로마토그래피 질량분석(LC-MS), 차세대 시퀀싱(NGS), 하이스루풋 스크리닝 기술을 통해 임상 시료를 보다 정확하고 빠르게 분석할 수 있습니다. 이러한 기술들은 검사 정확도를 향상시킬 뿐만 아니라, 임상시험에서 데이터의 무결성과 재현성을 향상시키고 있습니다. 클라우드 기반 실험실 정보 관리 시스템(LIMS)의 도입도 주요 발전 중 하나로, 여러 임상시험 기관에서 실시간으로 데이터를 공유하고 통합할 수 있게 되었습니다. AI를 활용한 데이터 분석도 임상 데이터의 패턴을 파악하고 임상시험 프로토콜을 최적화하여 임상시험의 효율성을 높이는 데 중요한 역할을 하고 있습니다. 규제 당국의 감시가 강화되고 고품질 임상시험 데이터가 요구되는 가운데, 중앙연구소는 기술을 활용하여 컴플라이언스, 효율성, 시험 결과의 신뢰성을 높이고 있습니다.

중앙연구소의 성장을 가속하는 시장 동향은?

중앙연구소 시장에 영향을 미치는 큰 흐름 중 하나는 바이오마커 중심의 의약품 개발이 강조되고 있다는 점입니다. 정밀의학 접근법에는 질병 특이적 바이오마커를 식별하기 위한 첨단 실험실 검사가 필요하며, 이는 제약회사와 중앙연구소의 협력 관계를 강화하는 데 기여하고 있습니다. 또한 분산형 임상시험과 가상 임상시험의 부상도 시장에 영향을 미치고 있으며, 중앙 실험실은 원격 샘플 수집 및 실시간 진단 서비스 제공에 적응하고 있습니다. 또 다른 주목할 만한 동향은 신흥 시장에서의 중앙 연구소 네트워크의 확대입니다. 아시아태평양 및 라틴아메리카 등의 지역에서 임상시험 활동이 활발해짐에 따라 주요 중앙 연구소는 해당 지역에 시설을 설립하고 국제 공동 임상시험을 지원하고 있습니다. 또한 규제 당국이 임상시험 수행 기준(GCLP)에 대한 중요성을 강조함에 따라 중앙연구소는 품질 보증 프로그램 및 인증 구상에 투자하고 있습니다. 이러한 추세는 향후 수년간 중앙 검사실 서비스의 진화를 더욱 구체화할 것으로 예측됩니다.

중앙 실험실 시장의 주요 성장 촉진요인은 무엇인가?

중앙 실험실 시장의 성장은 임상시험의 복잡성 증가, 정밀의료에 대한 수요 증가, 바이오마커 중심의 연구량 증가 등 여러 가지 요인에 의해 이루어지고 있습니다. 의약품 연구개발의 아웃소싱 동향도 매우 중요한 역할을 하고 있으며, 기업은 의약품 개발 일정을 앞당기고 운영 비용을 절감하기 위해 전문 연구소의 전문성을 요구하고 있습니다. 또한 희귀질환 및 생물제제를 중심으로 한 세계 임상시험 활동의 확대는 전문화된 중앙 실험실 서비스에 대한 수요를 촉진하고 있습니다. 엄격한 실험실 테스트 프로토콜을 요구하는 규제 요건은 시장 성장을 더욱 촉진하고 있습니다. 헬스케어 및 생명과학 산업이 디지털 전환과 AI 기반 분석을 지속적으로 도입하고 있는 가운데, 센트럴랩은 임상시험 및 의약품 개발 프로그램의 성공을 보장하는 데 필수적인 파트너로 자리매김할 것입니다.

부문

서비스 유형(유전자 서비스, 바이오마커 서비스, 미생물학 서비스, 해부 병리학/조직학, 검체 관리·보관, 특수화학 서비스, 기타 서비스), 최종사용자(제약회사, 바이오테크놀러지 기업, 학술·연구기관)

조사 대상 기업의 예

  • ACM Global Laboratories
  • Agilent Technologies
  • ALS Limited
  • BioAgilytix Labs
  • Bioanalytical Systems Inc.(BASi)
  • Bioclinica
  • BioReliance(Now part of Merck KGaA)
  • Celerion
  • Cerba Research
  • Charles River Laboratories
  • Covance(Now part of Labcorp)
  • CRL Central Laboratory
  • Eurofins Scientific
  • Frontage Laboratories
  • ICON plc
  • IQVIA
  • LabConnect
  • Labcorp
  • Medpace
  • Medpace Reference Laboratories

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.11

Global Central Labs Market to Reach US$4.6 Billion by 2030

The global market for Central Labs estimated at US$3.4 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Genetic Services, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Biomarker Services segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$924.0 Million While China is Forecast to Grow at 8.5% CAGR

The Central Labs market in the U.S. is estimated at US$924.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$931.0 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Central Labs Market - Key Trends & Drivers Summarized

Why Is the Demand for Central Labs Increasing?

Central laboratories play a critical role in clinical trials, providing standardized and high-quality testing services essential for drug development and regulatory approvals. The increasing number of clinical trials, particularly in oncology, neurology, and infectious diseases, is driving the demand for central lab services. Pharmaceutical and biotechnology companies are outsourcing laboratory functions to central labs to ensure consistency, compliance, and efficiency in diagnostic testing and biomarker analysis. Additionally, the complexity of clinical trials has increased, requiring specialized testing services such as pharmacokinetics, genomics, and companion diagnostics. The need for reliable and scalable laboratory services that can handle multi-site trials is pushing sponsors and contract research organizations (CROs) toward central lab partnerships. As the global clinical research landscape expands, the role of central labs in supporting precision medicine initiatives is becoming increasingly significant.

How Are Technological Advancements Transforming Central Labs?

Technological innovations in laboratory automation, artificial intelligence (AI), and digital pathology are revolutionizing central lab operations. Advanced liquid chromatography-mass spectrometry (LC-MS), next-generation sequencing (NGS), and high-throughput screening techniques are enabling more precise and rapid analysis of clinical samples. These technologies are not only improving test accuracy but also enhancing data integrity and reproducibility in clinical trials. The adoption of cloud-based laboratory information management systems (LIMS) is another key development, allowing real-time data sharing and integration across multiple trial sites. AI-driven data analytics are also playing a crucial role in improving trial efficiency by identifying patterns in clinical data and optimizing trial protocols. With increasing regulatory scrutiny and the demand for high-quality clinical trial data, central labs are leveraging technology to enhance compliance, efficiency, and reliability in test results.

What Market Trends Are Driving the Growth of Central Labs?

One of the major trends influencing the central labs market is the growing emphasis on biomarker-driven drug development. Precision medicine approaches require sophisticated laboratory testing to identify disease-specific biomarkers, leading to increased collaboration between pharmaceutical companies and central labs. The rise of decentralized and virtual clinical trials is also impacting the market, with central labs adapting to provide remote sample collection and real-time diagnostic services. Another notable trend is the expansion of central lab networks in emerging markets. As clinical trial activity grows in regions such as Asia-Pacific and Latin America, leading central labs are establishing facilities in these locations to support global trials. Additionally, regulatory authorities are placing greater emphasis on Good Clinical Laboratory Practices (GCLP), driving central labs to invest in quality assurance programs and accreditation initiatives. These trends are expected to further shape the evolution of central lab services in the coming years.

What Are the Key Growth Drivers in the Central Labs Market?

The growth in the Central Labs market is driven by several factors, including the increasing complexity of clinical trials, the growing demand for precision medicine, and the rising volume of biomarker-driven research. The outsourcing trend in pharmaceutical R&D is also playing a pivotal role, as companies seek specialized laboratory expertise to accelerate drug development timelines and reduce operational costs. Additionally, the expansion of global clinical trial activity, particularly in rare diseases and biologics, is fueling demand for specialized central lab services. Regulatory requirements mandating rigorous laboratory testing protocols are further reinforcing the market’s growth. As the healthcare and life sciences industries continue to embrace digital transformation and AI-powered analytics, central labs will remain essential partners in ensuring the success of clinical trials and drug development programs.

SCOPE OF STUDY:

The report analyzes the Central Labs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management and Storage, Special Chemistry Services, Other Services); End-Use (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • ACM Global Laboratories
  • Agilent Technologies
  • ALS Limited
  • BioAgilytix Labs
  • Bioanalytical Systems Inc. (BASi)
  • Bioclinica
  • BioReliance (Now part of Merck KGaA)
  • Celerion
  • Cerba Research
  • Charles River Laboratories
  • Covance (Now part of Labcorp)
  • CRL Central Laboratory
  • Eurofins Scientific
  • Frontage Laboratories
  • ICON plc
  • IQVIA
  • LabConnect
  • Labcorp
  • Medpace
  • Medpace Reference Laboratories

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Central Labs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Clinical Trial Activity Globally Propels Demand for Centralized Laboratory Services
    • Technological Advancements in Assay Development and Automation Strengthen Lab Efficiency
    • Stringent Regulatory Compliance and Data Integrity Standards Drive Central Lab Consolidation
    • Increased Focus on Biomarker Testing and Precision Medicine Expands Lab Service Portfolios
    • Growth in Complex Multi-Country Trials Throws Spotlight on Centralized Logistics and Sample Management
    • Digitalization and Adoption of LIMS and EDC Systems Enhance Workflow Efficiency and Data Accuracy
    • Expansion of Biologics and Cell & Gene Therapy Trials Sustains Demand for Specialized Lab Capabilities
    • Globalization of Clinical Trials Expands Need for Harmonized Testing Protocols and Standardization
    • Increased Outsourcing by Pharmaceutical Sponsors Propels Growth in Full-Service Lab Contracts
    • Public Health Crises and Pandemic Preparedness Strengthen Demand for Flexible and Rapid Testing Capacity
    • Quality Assurance and Accreditation Standards Strengthen Market Position of Certified Central Labs
    • Emergence of Specialty and Niche Testing Areas Drives Diversification in Central Lab Offerings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Central Labs Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Central Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Central Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Central Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Genetic Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Genetic Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Genetic Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biomarker Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biomarker Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biomarker Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Microbiology Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Microbiology Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Microbiology Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Anatomic Pathology / Histology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Anatomic Pathology / Histology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Anatomic Pathology / Histology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specimen Management & Storage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specimen Management & Storage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Specimen Management & Storage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Special Chemistry Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Special Chemistry Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Special Chemistry Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • JAPAN
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • CHINA
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • EUROPE
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Central Labs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Central Labs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Central Labs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • FRANCE
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • GERMANY
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Central Labs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Central Labs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Central Labs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • INDIA
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Central Labs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Central Labs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Central Labs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Central Labs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Central Labs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Central Labs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030
  • AFRICA
    • Central Labs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Central Labs by Service Type - Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Central Labs by Service Type - Percentage Breakdown of Value Sales for Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology / Histology, Specimen Management & Storage, Special Chemistry Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Central Labs by End-Use - Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for Central Labs by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제